şizofrenik bozuklukta cinsel işlev bozuklukları - Çukurova Üniversitesi
şizofrenik bozuklukta cinsel işlev bozuklukları - Çukurova Üniversitesi
şizofrenik bozuklukta cinsel işlev bozuklukları - Çukurova Üniversitesi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
97. Kim YK, Kim L and Lee MS. Risperidone and associated amenorrhea: A report of 5 cases. Journal<br />
of Clinical Psychiatry, 1999; 60:315-317.<br />
98. Markianos M, Hatzimanolis J and Lykouras L. Neuroendocrine responsivities of the pituitary<br />
dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine,<br />
risperidone, sulpride or haloperidol. European Archives of Psychiatry and Clinical Neuroscience,<br />
2001; 251(3):141-146.<br />
99. Richelson E and Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer<br />
generation compounds. Life Sciences, 2000; 68(1):29-39.<br />
100. Matthews SC and Dimsdale JE. Priapism after a suicide attempt by ingestion of olanzapine and<br />
gabapentin. [Letter]. Psychosomatics, 2001; 42(3):280-281.<br />
101. Costa AM, de Lima MS, Faria M, et al. A naturalistic, 9-month follow-up, comparing olanzapine<br />
and conventional antipsychotics on sexual function and hormonal profile for males with<br />
schizophrenia. J. Psychopharmacol 2006 [Epub ahead of print].<br />
102. Bitter I, Basson BR, Dossenbach MR. Antipsychotic tratment and sexual functioning in fist-time<br />
neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 2005; 20:19-21.<br />
103. Dossenbach M, Dyachkova Y, Pirildar S, et al. Effects of atypical and typical antipsychotic<br />
treatments on sexual function in patients with schizophrenia: 12-month results from the<br />
Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006;<br />
21:251-258.<br />
104. King DJ, Link CG and Kowalcyk B. A comparison of bd and tid dose regimens of quetiapine in the<br />
treatment of schizophrenia. Psychopharmacology. 1998; 137:139-146.<br />
105. Goldstein JM and Cantillon M. “Low incidence of reproductive/hormonal side effects with<br />
Seroquel is supported by its lack of elevation of plasma prolactin concentrations.” Paper presented at<br />
the 36th Annual Meeting of the American College of Neuropsychopharmacology. December 1997;<br />
Honolulu, HI.<br />
106. Pais VM and Ayvazian PJ. Priapism from quetiapine overdose: First report and proposal of<br />
mechanism. [Abstract]. Urology, 2001; 58(3):462.<br />
107. AstraZeneca Pharmaceuticals. “Seroquel Tablets.” Product monograph. Wilmington, DE: 2001;<br />
AstraZeneca.<br />
108. Montejo Gonzalelez AL, Rico-Villademoros F, Tafalla M, Majades S. A 6-month prospective<br />
observational study on the effects of quetiapine on sexual functioning. J. Clin Psychopharmacol<br />
2005; 25:533-538.<br />
109. Atmaca M, Kuloğlu M, Tezcan E. A new atypical antipsychotic: quetiapine-induced sexual<br />
dysfunctions. Int J Import Res 2005: 17:201-203.<br />
110. Ananth J, Burgoyne K, Smith M and Gadasalli R. “Prolactin Levels and New Antipsychotics.”<br />
Paper presented at the 21st Annual Congress, European College of Neuropsychopharmacology,<br />
Glasgow, July 1998; Scotland.<br />
111. Reeves RR and Kimble R. Prolonged erections associated with ziprasidone treatment: A case<br />
report. Journal of Clinical Psychiatry, 2003; 64:97-98.<br />
58